PDL BioPharma Total Assets 2006-2020 | PDLI

PDL BioPharma total assets from 2006 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
PDL BioPharma Annual Total Assets
(Millions of US $)
2019 $716
2018 $964
2017 $1,243
2016 $1,215
2015 $1,012
2014 $962
2013 $544
2012 $280
2011 $269
2010 $317
2009 $338
2008 $191
2007 $1,192
2006 $1,142
2005 $1,163
PDL BioPharma Quarterly Total Assets
(Millions of US $)
2020-03-31 $660
2019-12-31 $717
2019-09-30 $865
2019-06-30 $890
2019-03-31 $924
2018-12-31 $964
2018-09-30 $984
2018-06-30 $946
2018-03-31 $1,100
2017-12-31 $1,243
2017-09-30 $1,224
2017-06-30 $1,302
2017-03-31 $1,238
2016-12-31 $1,215
2016-09-30 $1,216
2016-06-30 $1,049
2016-03-31 $1,055
2015-12-31 $1,012
2015-09-30 $1,021
2015-06-30 $996
2015-03-31 $1,114
2014-12-31 $962
2014-09-30 $980
2014-06-30 $916
2014-03-31 $853
2013-12-31 $544
2013-09-30 $430
2013-06-30 $401
2013-03-31 $313
2012-12-31 $280
2012-09-30 $250
2012-06-30 $260
2012-03-31 $235
2011-12-31 $269
2011-09-30 $271
2011-06-30 $284
2011-03-31 $249
2010-12-31 $317
2010-09-30 $258
2010-06-30 $272
2010-03-31 $358
2009-12-31 $338
2009-09-30 $264
2009-06-30 $218
2009-03-31 $219
2008-12-31 $191
2008-09-30 $718
2008-06-30 $654
2008-03-31 $1,118
2007-12-31 $1,192
2007-09-30 $1,163
2007-06-30 $1,184
2007-03-31 $1,121
2006-12-31 $1,142
2006-09-30 $1,197
2006-06-30 $1,180
2006-03-31 $1,173
2005-12-31 $1,163
2005-09-30 $1,177
2005-06-30 $1,055
2005-03-31 $1,049
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.381B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.120B 14.88
Gilead Sciences (GILD) United States $97.628B 12.66
CSL (CSLLY) Australia $84.053B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.661B 51.33
Regeneron Pharmaceuticals (REGN) United States $67.420B 25.99
Illumina (ILMN) United States $53.368B 54.84
Biogen (BIIB) United States $50.113B 8.58
Seattle Genetics (SGEN) United States $27.213B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.477B 11.38
Moderna (MRNA) United States $22.830B 0.00
Incyte (INCY) United States $22.152B 0.00
Genmab (GMAB) Denmark $19.891B 16.38
Genmab (GNMSF) Denmark $19.309B 57.33
BioMarin Pharmaceutical (BMRN) United States $19.268B 174.67
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.532B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.144B 38.92
Exact Sciences (EXAS) United States $12.860B 0.00
BeiGene (BGNE) Cayman Islands $12.803B 0.00
Sarepta Therapeutics (SRPT) United States $11.875B 0.00
BioNTech SE (BNTX) Germany $11.207B 0.00
Bio-Techne Corp (TECH) United States $10.121B 66.87
QIAGEN (QGEN) Netherlands $9.973B 29.00
Horizon Therapeutics Public (HZNP) Ireland $9.678B 23.82
ARGENX SE-ADR (ARGX) Netherlands $9.384B 0.00
Guardant Health (GH) United States $8.549B 0.00
Immunomedics (IMMU) United States $7.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.743B 0.00
Exelixis (EXEL) United States $7.578B 26.57
Ascendis Pharma (ASND) Denmark $6.981B 0.00
Repligen (RGEN) United States $6.851B 120.16
Acceleron Pharma (XLRN) United States $5.320B 0.00
Adaptive Biotechnologies (ADPT) United States $4.911B 0.00
Reata Pharmaceuticals (RETA) United States $4.830B 0.00
MyoKardia (MYOK) United States $4.775B 0.00
Emergent Biosolutions (EBS) United States $4.377B 28.69
China Biologic Products (CBPO) China $4.360B 24.24
Mirati Therapeutics (MRTX) United States $4.329B 0.00
Zai Lab (ZLAB) China $4.323B 0.00
Global Blood Therapeutics (GBT) United States $4.261B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Ultragenyx Pharmaceutical (RARE) United States $4.084B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.941B 86.11
Momenta Pharmaceuticals (MNTA) United States $3.705B 0.00
Bluebird Bio (BLUE) United States $3.541B 0.00
Blueprint Medicines (BPMC) United States $3.530B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.272B 0.00
Amicus Therapeutics (FOLD) United States $3.214B 0.00
Arena Pharmaceuticals (ARNA) United States $3.009B 0.00
UniQure (QURE) Netherlands $2.976B 0.00
Denali Therapeutics (DNLI) United States $2.940B 0.00
NeoGenomics (NEO) United States $2.811B 205.31
Novavax (NVAX) United States $2.668B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Alkermes (ALKS) Ireland $2.597B 51.13
Alector (ALEC) United States $2.584B 0.00
Fate Therapeutics (FATE) United States $2.520B 0.00
Insmed (INSM) United States $2.454B 0.00
Viela Bio (VIE) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.380B 0.00
Inovio Pharmaceuticals (INO) United States $2.332B 0.00
Principia Biopharma (PRNB) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.885B 0.00
Epizyme (EPZM) United States $1.774B 0.00
Zymeworks (ZYME) Canada $1.736B 0.00
Adverum Biotechnologies (ADVM) United States $1.650B 0.00
Ligand Pharmaceuticals (LGND) United States $1.630B 63.48
Dicerna Pharmaceuticals (DRNA) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.576B 0.00
Twist Bioscience (TWST) United States $1.555B 0.00
Zealand Pharma (ZEAL) Denmark $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Akcea Therapeutics (AKCA) United States $1.506B 0.00
Mesoblast (MESO) Australia $1.490B 0.00
Editas Medicine (EDIT) United States $1.489B 0.00
Arcus Biosciences (RCUS) United States $1.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.440B 0.00
I-Mab (IMAB) China $1.423B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
REGENXBIO (RGNX) United States $1.403B 0.00
Intra-Cellular Therapies (ITCI) United States $1.388B 0.00
NGM Biopharmaceuticals (NGM) United States $1.344B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.322B 9.23
Beam Therapeutics (BEAM) United States $1.315B 0.00
Arvinas (ARVN) United States $1.303B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.083B 55.88
Nabriva Therapeutics AG (NBRV) Ireland $1.079B 0.00
Sorrento Therapeutics (SRNE) United States $1.059B 0.00
Compugen (CGEN) Israel $1.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Athenex (ATNX) United States $0.887B 0.00
NextCure (NXTC) United States $0.859B 0.00
Heska (HSKA) United States $0.826B 0.00
Cue Biopharma (CUE) United States $0.787B 0.00
Cellectis S.A (CLLS) France $0.784B 0.00
Alcobra (ARCT) United States $0.775B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.752B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Codexis (CDXS) United States $0.733B 0.00
Kadmon Holdings (KDMN) United States $0.711B 0.00
Retrophin (RTRX) United States $0.677B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
NantKwest (NK) United States $0.664B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Vericel (VCEL) United States $0.649B 119.83
Vanda Pharmaceuticals (VNDA) United States $0.639B 5.48
Morphic Holding (MORF) United States $0.636B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.634B 0.00
Bellus Health (BLU) Canada $0.632B 0.00
Agenus (AGEN) United States $0.624B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.585B 0.00
Frequency Therapeutics (FREQ) United States $0.576B 0.00
Athersys (ATHX) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.564B 0.00
MeiraGTx Holdings (MGTX) United States $0.554B 0.00
Scholar Rock Holding (SRRK) United States $0.550B 0.00
DBV Technologies S.A (DBVT) France $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.532B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 0.00
AnaptysBio (ANAB) United States $0.520B 0.00
VBI Vaccines (VBIV) United States $0.503B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.502B 0.00
UROGEN PHARMA (URGN) United States $0.490B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.479B 0.00
BioDelivery Sciences (BDSI) United States $0.478B 25.16
Anika Therapeutics (ANIK) United States $0.476B 15.31
Aquinox Pharmaceuticals (NLTX) United States $0.467B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
CytomX Therapeutics (CTMX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.393B 0.00
ANI Pharmaceuticals (ANIP) United States $0.376B 7.45
Intrexon (PGEN) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Kamada (KMDA) Israel $0.349B 14.54
Avid Bioservices (CDMO) United States $0.330B 0.00
Menlo Therapeutics (MNLO) United States $0.326B 0.00
Geron (GERN) United States $0.323B 0.00
MannKind (MNKD) United States $0.322B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.316B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Verastem (VSTM) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.267B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Liquidia Technologies (LQDA) United States $0.262B 0.00
Starpharma Holdings (SPHRY) Australia $0.259B 0.00
Affimed (AFMD) Germany $0.251B 0.00
Pfenex (PFNX) United States $0.250B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Exicure (XCUR) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
ARAVIVE, INC (ARAV) United States $0.204B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.194B 0.00
Cerecor (CERC) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
IBio (IBIO) United States $0.189B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Aytu Bioscience (AYTU) United States $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Celyad SA (CYAD) Belgium $0.158B 0.00
TELA Bio (TELA) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.150B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Trevena (TRVN) United States $0.139B 0.00
Theratechnologies (THTX) Canada $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.132B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.131B 0.00
VolitionRX (VNRX) United States $0.127B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.117B 0.00
Palatin Technologies (PTN) United States $0.116B 2.98
CorMedix Inc (CRMD) United States $0.115B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
Protalix BioTherapeutics (PLX) Israel $0.108B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Organovo Holdings (ONVO) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Happiness Biotech Group (HAPP) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Signal Genetics (MGEN) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
OvaScience (MLND) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Curis (CRIS) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.030B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
Bionano Genomics (BNGO) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00